China · Delayed Price · Currency is CNY GKHT Medical Technology Statistics
Total Valuation
SHE:301370 has a market cap or net worth of CNY 4.06 billion. The enterprise value is 4.90 billion.
| Market Cap | 4.06B |
| Enterprise Value | 4.90B |
Important Dates
The last earnings date was Saturday, August 29, 2026.
| Earnings Date | Aug 29, 2026 |
| Ex-Dividend Date | Jun 17, 2026 |
Share Statistics
SHE:301370 has 466.96 million shares outstanding. The number of shares has increased by 12.18% in one year.
| Current Share Class | 466.96M |
| Shares Outstanding | 466.96M |
| Shares Change (YoY) | +12.18% |
| Shares Change (QoQ) | +58.19% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 17.28% |
| Float | 229.10M |
Valuation Ratios
The trailing PE ratio is 168.09.
| PE Ratio | 168.09 |
| Forward PE | n/a |
| PS Ratio | 0.63 |
| PB Ratio | 1.62 |
| P/TBV Ratio | 1.74 |
| P/FCF Ratio | 9.26 |
| P/OCF Ratio | 6.84 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.31, with an EV/FCF ratio of 11.19.
| EV / Earnings | 183.15 |
| EV / Sales | 0.76 |
| EV / EBITDA | 31.31 |
| EV / EBIT | 53.34 |
| EV / FCF | 11.19 |
Financial Position
The company has a current ratio of 1.49, with a Debt / Equity ratio of 0.57.
| Current Ratio | 1.49 |
| Quick Ratio | 0.58 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | 9.11 |
| Debt / FCF | 3.25 |
| Interest Coverage | 5.80 |
Financial Efficiency
Return on equity (ROE) is 0.65% and return on invested capital (ROIC) is 0.96%.
| Return on Equity (ROE) | 0.65% |
| Return on Assets (ROA) | 0.90% |
| Return on Invested Capital (ROIC) | 0.96% |
| Return on Capital Employed (ROCE) | 3.45% |
| Weighted Average Cost of Capital (WACC) | 4.30% |
| Revenue Per Employee | 7.41M |
| Profits Per Employee | 30,654 |
| Employee Count | 873 |
| Asset Turnover | 1.02 |
| Inventory Turnover | 2.20 |
Taxes
In the past 12 months, SHE:301370 has paid 30.76 million in taxes.
| Income Tax | 30.76M |
| Effective Tax Rate | 65.39% |
Stock Price Statistics
The stock price has decreased by -20.64% in the last 52 weeks. The beta is 0.26, so SHE:301370's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -20.64% |
| 50-Day Moving Average | 8.69 |
| 200-Day Moving Average | 10.33 |
| Relative Strength Index (RSI) | 45.05 |
| Average Volume (20 Days) | 4,462,520 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301370 had revenue of CNY 6.47 billion and earned 26.76 million in profits. Earnings per share was 0.05.
| Revenue | 6.47B |
| Gross Profit | 590.88M |
| Operating Income | 91.88M |
| Pretax Income | 47.04M |
| Net Income | 26.76M |
| EBITDA | 134.17M |
| EBIT | 91.88M |
| Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 618.96 million in cash and 1.43 billion in debt, with a net cash position of -806.54 million or -1.73 per share.
| Cash & Cash Equivalents | 618.96M |
| Total Debt | 1.43B |
| Net Cash | -806.54M |
| Net Cash Per Share | -1.73 |
| Equity (Book Value) | 2.50B |
| Book Value Per Share | 3.75 |
| Working Capital | 1.77B |
Cash Flow
In the last 12 months, operating cash flow was 593.27 million and capital expenditures -155.18 million, giving a free cash flow of 438.09 million.
| Operating Cash Flow | 593.27M |
| Capital Expenditures | -155.18M |
| Depreciation & Amortization | 42.29M |
| Net Borrowing | -389.44M |
| Free Cash Flow | 438.09M |
| FCF Per Share | 0.94 |
Margins
Gross margin is 9.13%, with operating and profit margins of 1.42% and 0.41%.
| Gross Margin | 9.13% |
| Operating Margin | 1.42% |
| Pretax Margin | 0.73% |
| Profit Margin | 0.41% |
| EBITDA Margin | 2.07% |
| EBIT Margin | 1.42% |
| FCF Margin | 6.77% |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 1.39%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 1.39% |
| Dividend Growth (YoY) | 45.24% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 297.19% |
| Buyback Yield | -12.18% |
| Shareholder Yield | -10.79% |
| Earnings Yield | 0.66% |
| FCF Yield | 10.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |